Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107). | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Jahan T, Gu L, Kratzke R, Dudek A, Otterson GA, Wang X, Green M, Vokes EE, Kindler HL

Publication

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1159262

Publication Year

2011

PubMed ID

22197613